{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T08:46:05Z","timestamp":1698396365356},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologie"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s00292-023-01216-2","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T19:03:49Z","timestamp":1692731029000},"page":"338-347","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lymphome bei Kindern und Adoleszenten","Lymphomas in children and adolescents"],"prefix":"10.1007","volume":"44","author":[{"given":"Wolfram","family":"Klapper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,22]]},"reference":[{"key":"1216_CR1","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio\u00a0R, Amador\u00a0C, Anagnostopoulos\u00a0I et\u00a0al (2022) The 5th\u00a0edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia 36:1720\u20131748","journal-title":"Leukemia"},{"key":"1216_CR2","doi-asserted-by":"publisher","first-page":"e28416","DOI":"10.1002\/pbc.28416","volume":"67","author":"A Attarbaschi","year":"2020","unstructured":"Attarbaschi\u00a0A, Abla\u00a0O, Arias Padilla\u00a0L et al (2020) Rare non-Hodgkin lymphoma of childhood and adolescence: A\u00a0consensus diagnostic and therapeutic approach to pediatric-type follicular lymphoma, marginal zone lymphoma, and nonanaplastic peripheral T\u2011cell lymphoma. Pediatr Blood Cancer 67:e28416","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"1216_CR3","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1007\/s00277-013-1785-2","volume":"1","author":"A Attarbaschi","year":"2013","unstructured":"Attarbaschi A, Beishuizen A, Mann G et al (2013) Children and adolescents with follicular lymphoma have an excellent prognosis with either limited chemotherapy or with a\u00a0\u201cwatch and wait\u201d strategy after complete resection. Ann Hematol 1(1):1537\u20131541. https:\/\/doi.org\/10.1007\/s00277-013-1785-2","journal-title":"Ann Hematol"},{"key":"1216_CR4","unstructured":"Au-Yeung\u00a0RKHK (2019) Features of Pediatric B\u2011lymphoblastic lymphoma with KMT2A rearrangements in the German NHL-BFM Group. In: The 108th Annual Meeting of the Japanese Society of Pathology. Proceedings of the Japanese Society of Pathology Tokyo, S 420"},{"key":"1216_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16578","author":"RKH Au-Yeung","year":"2020","unstructured":"Au-Yeung RKH, Arias Padilla L, Zimmermann M et al (2020) Experience with provisional WHO-entities large B\u2011cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group. Br J Haematol. https:\/\/doi.org\/10.1111\/bjh.16578","journal-title":"Br J Haematol"},{"key":"1216_CR6","doi-asserted-by":"publisher","first-page":"e213","DOI":"10.1016\/S2352-3026(22)00374-X","volume":"10","author":"A Beishuizen","year":"2023","unstructured":"Beishuizen\u00a0A, Mellgren\u00a0K, Andr\u00e9s\u00a0M et al (2023) Improving outcomes of childhood and young adult non-Hodgkin lymphoma: 25\u00a0years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma. Lancet Haematol 10:e213\u2013e224","journal-title":"Lancet Haematol"},{"key":"1216_CR7","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1038\/s41467-022-31355-8","volume":"13","author":"B Burkhardt","year":"2022","unstructured":"Burkhardt\u00a0B, Michgehl\u00a0U, Rohde\u00a0J et\u00a0al (2022) Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age. Nat Commun 13:3881","journal-title":"Nat Commun"},{"key":"1216_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1365-2141.2005.05735.x","volume":"131","author":"B Burkhardt","year":"2005","unstructured":"Burkhardt\u00a0B, Zimmermann\u00a0M, Oschlies\u00a0I et al (2005) The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence. Br J Haematol 131:39\u201349","journal-title":"Br J Haematol"},{"key":"1216_CR9","volume-title":"Pathology and genetics of tumours of haematopoetic and lymphoid tissues","author":"E Jaffe","year":"2001","unstructured":"Jaffe\u00a0E, H\u00a0H, S\u00a0H et\u00a0al (2001) Pathology and genetics of tumours of haematopoetic and lymphoid tissues. IARC Press, Lyon, France"},{"key":"1216_CR10","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1182\/blood-2011-10-388470","volume":"119","author":"W Klapper","year":"2012","unstructured":"Klapper\u00a0W, Kreuz\u00a0M, Kohler\u00a0CW et al (2012) Patient age at diagnosis is associated with the molecular characteristics of diffuse large B\u2011cell lymphoma. Blood 119:1882\u20131887","journal-title":"Blood"},{"key":"1216_CR11","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/bjh.13216","volume":"168","author":"U Kontny","year":"2015","unstructured":"Kontny\u00a0U, Oschlies\u00a0I, Woessmann\u00a0W et al (2015) Non-anaplastic peripheral T\u2011cell lymphoma in children and adolescents\u2014a retrospective analysis of the NHL-BFM study group. Br J Haematol 168:835\u2013844","journal-title":"Br J Haematol"},{"key":"1216_CR12","doi-asserted-by":"publisher","first-page":"4669","DOI":"10.1200\/JCO.2011.36.5411","volume":"29","author":"L Lamant","year":"2011","unstructured":"Lamant\u00a0L, Mccarthy\u00a0K, D\u2019amore\u00a0E et al (2011) Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large-cell lymphoma: results of the ALCL99 study. J\u00a0Clin Oncol 29:4669\u20134676","journal-title":"J Clin Oncol"},{"key":"1216_CR13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00428-022-03432-2","volume":"482","author":"C Laurent","year":"2023","unstructured":"Laurent\u00a0C, Cook\u00a0JR, Yoshino\u00a0T et\u00a0al (2023) Follicular lymphoma and marginal zone lymphoma: how many diseases? Virchows Arch 482:149\u2013162","journal-title":"Virchows Arch"},{"key":"1216_CR14","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/bjh.14868","volume":"182","author":"O Makarova","year":"2018","unstructured":"Makarova\u00a0O, Oschlies\u00a0I, Muller\u00a0S et\u00a0al (2018) Excellent outcome with limited treatment in paediatric patients with marginal zone lymphoma. Br J Haematol 182:735\u2013739","journal-title":"Br J Haematol"},{"key":"1216_CR15","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1055\/s-0035-1559664","volume":"227","author":"C Mauz-K\u00f6rholz","year":"2015","unstructured":"Mauz-K\u00f6rholz\u00a0C, Lange\u00a0T, Hasenclever\u00a0D et al (2015) Pediatric nodular lymphocyte-predominant Hodgkin Lymphoma: treatment recommendations of the GPOH-HD study group. Klin Padiatr 227:314\u2013321","journal-title":"Klin Padiatr"},{"key":"1216_CR16","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1200\/JCO.2014.59.4853","volume":"33","author":"C Mauz-K\u00f6rholz","year":"2015","unstructured":"Mauz-K\u00f6rholz\u00a0C, Metzger\u00a0ML, Kelly\u00a0KM et al (2015) Pediatric Hodgkin Lymphoma. J\u00a0Clin Oncol 33:2975\u20132985","journal-title":"J Clin Oncol"},{"key":"1216_CR17","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1056\/NEJMoa1915315","volume":"382","author":"V Minard-Colin","year":"2020","unstructured":"Minard-Colin\u00a0V, Aup\u00e9rin\u00a0A, Pillon\u00a0M et al (2020) Rituximab for High-Risk, Mature B\u2011Cell Non-Hodgkin\u2019s Lymphoma in Children. N\u00a0Engl J Med 382:2207\u20132219","journal-title":"N Engl J Med"},{"key":"1216_CR18","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1038\/s41375-022-01626-w","volume":"36","author":"P M\u00f6ker","year":"2022","unstructured":"M\u00f6ker\u00a0P, Zur Stadt\u00a0U, Zimmermann\u00a0M et al (2022) Characterization of IG-MYC-breakpoints and their application for quantitative minimal disease monitoring in high-risk pediatric Burkitt-lymphoma and -leukemia. Leukemia 36:2343\u20132346","journal-title":"Leukemia"},{"key":"1216_CR19","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1182\/blood.2019001126","volume":"134","author":"A Mottok","year":"2019","unstructured":"Mottok\u00a0A, Hung\u00a0SS, Chavez\u00a0EA et al (2019) Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B\u2011cell lymphoma. Blood 134:802\u2013813","journal-title":"Blood"},{"key":"1216_CR20","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1097\/PAS.0b013e318213e90e","volume":"35","author":"I Oschlies","year":"2011","unstructured":"Oschlies\u00a0I, Burkhardt\u00a0B, Chassagne-Clement\u00a0C et al (2011) Diagnosis and immunophenotype of 188 pediatric lymphoblastic lymphomas treated within a\u00a0randomized prospective trial: experiences and preliminary recommendations from the European childhood lymphoma pathology panel. Am J Surg Pathol 35:836\u2013844","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"1216_CR21","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3324\/haematol.2009.013177","volume":"95","author":"I Oschlies","year":"2009","unstructured":"Oschlies I, Salaverria I, Mahn F et al (2009) Pediatric follicular lymphoma\u2014a\u00a0clinico-pathological study of a\u00a0population-based series of patients treated within the NHL-BFM (Berlin-Frankfurt-Munster) multicenter trials. Haematologica 95(2):253\u2013259. https:\/\/doi.org\/10.3324\/haematol.2009.013177","journal-title":"Haematologica"},{"key":"1216_CR22","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/bjh.17874","volume":"196","author":"J Richter","year":"2022","unstructured":"Richter\u00a0J, John\u00a0K, Staiger\u00a0AM et al (2022) Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features. Br J Haematol 196:681\u2013689","journal-title":"Br J Haematol"},{"key":"1216_CR23","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1182\/blood-2013-06-507996","volume":"123","author":"I Salaverria","year":"2014","unstructured":"Salaverria\u00a0I, Martin-Guerrero\u00a0I, Wagener\u00a0R et al (2014) A recurrent 11q aberration pattern characterizes a\u00a0subset of MYC-negative high-grade B\u2011cell lymphomas resembling Burkitt lymphoma. Blood 123:1187\u20131198","journal-title":"Blood"},{"key":"1216_CR24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1182\/blood-2011-01-330795","volume":"118","author":"I Salaverria","year":"2011","unstructured":"Salaverria\u00a0I, Philipp\u00a0C, Oschlies\u00a0I et al (2011) Translocations activating IRF4 identify a\u00a0subtype of germinal center-derived B\u2011cell lymphoma affecting predominantly children and young adults. Blood 118:139\u2013147","journal-title":"Blood"},{"key":"1216_CR25","doi-asserted-by":"publisher","first-page":"4661","DOI":"10.1182\/bloodadvances.2022007322","volume":"6","author":"J Salmeron-Villalobos","year":"2022","unstructured":"Salmeron-Villalobos\u00a0J, Egan\u00a0C, Borgmann\u00a0V et al (2022) A unifying hypothesis for PNMZL and PTFL: morphological variants with a\u00a0common molecular profile. Blood Adv 6:4661\u20134674","journal-title":"Blood Adv"},{"key":"1216_CR26","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1182\/bloodadvances.2020001923","volume":"4","author":"C Sarkozy","year":"2020","unstructured":"Sarkozy\u00a0C, Chong\u00a0L, Takata\u00a0K et\u00a0al (2020) Gene expression profiling of gray zone lymphoma. Blood Adv 4:2523\u20132535","journal-title":"Blood Adv"},{"key":"1216_CR27","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/PAS.0000000000001198","volume":"43","author":"C Sarkozy","year":"2019","unstructured":"Sarkozy\u00a0C, Copie-Bergman\u00a0C, Damotte\u00a0D et al (2019) Gray-zone Lymphoma between cHL and large B\u2011cell Lymphoma: a\u00a0Histopathologic series from the LYSA. Am J Surg Pathol 43:341\u2013351","journal-title":"Am J Surg Pathol"},{"key":"1216_CR28","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1182\/blood.2020007507","volume":"137","author":"C Sarkozy","year":"2021","unstructured":"Sarkozy\u00a0C, Hung\u00a0SS, Chavez\u00a0EA et\u00a0al (2021) Mutational landscape of gray zone lymphoma. Blood 137:1765\u20131776","journal-title":"Blood"},{"key":"1216_CR29","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/bjh.14812","volume":"179","author":"M Szczepanowski","year":"2017","unstructured":"Szczepanowski\u00a0M, Lange\u00a0J, Kohler\u00a0CW et al (2017) Cell-of-origin classification by gene expression and MYC-rearrangements in diffuse large B\u2011cell lymphoma of children and adolescents. Br J Haematol 179:116\u2013119","journal-title":"Br J Haematol"},{"key":"1216_CR30","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1182\/blood.2022016534","volume":"141","author":"N Thomas","year":"2023","unstructured":"Thomas\u00a0N, Dreval\u00a0K, Gerhard\u00a0DS et\u00a0al (2023) Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma. Blood 141:904\u2013916","journal-title":"Blood"},{"key":"1216_CR31","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1056\/NEJMc1305983","volume":"369","author":"W Woessmann","year":"2013","unstructured":"Woessmann\u00a0W, Lisfeld\u00a0J, Burkhardt\u00a0B (2013) Therapy in primary mediastinal B\u2011cell lymphoma. N\u00a0Engl J Med 369:282","journal-title":"N Engl J Med"}],"container-title":["Die Pathologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-023-01216-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00292-023-01216-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-023-01216-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T09:02:19Z","timestamp":1698310939000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00292-023-01216-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,22]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["1216"],"URL":"https:\/\/doi.org\/10.1007\/s00292-023-01216-2","relation":{},"ISSN":["2731-7188","2731-7196"],"issn-type":[{"value":"2731-7188","type":"print"},{"value":"2731-7196","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,22]]},"assertion":[{"value":"3 July 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"W.\u00a0Klapper gibt an: Mein Universit\u00e4tsklinikum erh\u00e4lt Forschungsf\u00f6rderung und Beratungshonorare von Roche, Amgen, Takeda, Janssen. Keine Mittel gehen privat zu meinen H\u00e4nden und keine Mittel bzw. T\u00e4tigkeiten daf\u00fcr haben inhaltlichen Bezug zu dem hier verfassten Manuskript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden vom Autor keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}